By Sid Ruttala When oil spikes, investors tend to reach for the same old script. Energy prices go up, energy stocks follow, cash flows surge, dividends look safer, and suddenly what felt pedestrian last month starts to look positively strategic. That instinct is...
By Ron Shamgar One of the enduring truths in small and mid cap investing is that the market does not always reward a good result. Sometimes it does the opposite. A company can deliver strong revenue growth, solid cash conversion, reaffirm guidance, expand into...
Written by Rob Swift There is a peculiar habit in markets, one that repeats itself with almost comic reliability, where investors become so transfixed by what is loudly obvious that they entirely miss what is quietly important, and today feels very much like one of...
By Ron Shamgar Markets have a curious habit of extrapolating the recent past far into the future. When a company experiences a difficult period, investors tend to assume that weakness will persist indefinitely. Yet history shows that some of the most compelling...
By Ron Shamgar In investing, there are moments when the market slowly recognises value and rewards patient shareholders. Then there are moments when value is crystallised suddenly through corporate action. The recent takeover proposal for ClearView Wealth (ASX: CVW)...
By Darren Katz The geopolitical temperature in the Middle East is rising. The United States has increased its military posture in the region, naval assets are repositioning, and rhetoric between Washington and Tehran is intensifying. Whether conflict becomes kinetic...
Written by Ron Shamgar The Ozempic moment for SaaS refers to a pivotal disruption scenario where a transformative technology threatens to erode or fundamentally reshape an established market leader's core business model, much like the hype around Ozempic (and other...
Written by Robert Swift Investors adore narratives that offer emotional comfort. “AI will save us”, “recession is cancelled”, “central banks have everything under control”, and other fairytales that make market commentators feel clever. The inconvenient truth is that...
Edu Holdings, Credit Clear, and Austco Healthcare are three disciplined operators gaining momentum across education, collections technology, and healthcare systems. With improving earnings quality, attractive valuations, and multi-year structural tailwinds, these companies represent some of the most compelling quiet achievers on the ASX.
Written by Ron Shamgar The Inflection Point In the small-cap universe, few transformations are as profound as when a domestic success story becomes a true global operator. For Pureprofile (ASX: PPL), that turning point has arrived. In the September quarter, the...
Written by Sid Ruttala Few companies are more deeply embedded in the Australian economy than Woolworths. It sits at the heart of everyday spending, riding the same tailwinds and headwinds that shape the national mood. When households tighten their belts, Woolworths...
Written by Ron Shamgar After two years of relative underperformance, Australian small and mid caps are finally showing signs of life. With inflation easing, rate cuts now on the horizon, and investor sentiment gradually shifting back toward growth, we believe the next...
